DE602006014514D1 - - Google Patents

Info

Publication number
DE602006014514D1
DE602006014514D1 DE602006014514T DE602006014514T DE602006014514D1 DE 602006014514 D1 DE602006014514 D1 DE 602006014514D1 DE 602006014514 T DE602006014514 T DE 602006014514T DE 602006014514 T DE602006014514 T DE 602006014514T DE 602006014514 D1 DE602006014514 D1 DE 602006014514D1
Authority
DE
Germany
Prior art keywords
treating
muscular dystrophy
idebenone
medicament
loss
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602006014514T
Other languages
German (de)
English (en)
Inventor
Thomas Meier
Gunnar Buyse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santhera Pharmaceuticals Schweiz GmbH
Original Assignee
Santhera Pharmaceuticals Schweiz GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36572153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602006014514(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Santhera Pharmaceuticals Schweiz GmbH filed Critical Santhera Pharmaceuticals Schweiz GmbH
Publication of DE602006014514D1 publication Critical patent/DE602006014514D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE602006014514T 2005-03-21 2006-03-20 Expired - Lifetime DE602006014514D1 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05006137 2005-03-21
PCT/EP2006/002536 WO2006100017A1 (en) 2005-03-21 2006-03-20 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1 ,4- benzoquinone for the treatment of muscular dystrophies

Publications (1)

Publication Number Publication Date
DE602006014514D1 true DE602006014514D1 (enExample) 2010-07-08

Family

ID=36572153

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006014514T Expired - Lifetime DE602006014514D1 (enExample) 2005-03-21 2006-03-20

Country Status (17)

Country Link
US (1) US7977388B2 (enExample)
EP (1) EP1861080B1 (enExample)
JP (1) JP4896123B2 (enExample)
AT (1) ATE468849T1 (enExample)
AU (1) AU2006226623B2 (enExample)
CA (1) CA2602290C (enExample)
CY (1) CY1110182T1 (enExample)
DE (1) DE602006014514D1 (enExample)
DK (1) DK1861080T3 (enExample)
ES (1) ES2345353T3 (enExample)
MX (1) MX2007011571A (enExample)
NZ (1) NZ561235A (enExample)
PL (1) PL1861080T3 (enExample)
PT (1) PT1861080E (enExample)
SI (1) SI1861080T1 (enExample)
WO (1) WO2006100017A1 (enExample)
ZA (1) ZA200707833B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2046348B1 (en) 2006-08-01 2015-07-22 Phrixus Pharmaceuticals, Incorporated Use of poloxamer for the prevention and/or treatment of heart failure
EP1891946A1 (en) * 2006-08-14 2008-02-27 Santhera Pharmaceuticals (Schweiz) AG Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone
US8852568B2 (en) 2007-12-17 2014-10-07 The Regents Of The University Of Michigan Compositions and methods for treating and preventing skeletal muscle deficiencies
DK2108366T3 (da) * 2008-04-09 2012-01-30 Santhera Pharmaceuticals Ch Idebenon til behandling af respiratorisk sygdom ved muskeldystrofi
EP2246048A1 (en) * 2009-04-30 2010-11-03 Santhera Pharmaceuticals (Schweiz) AG Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
DK2605769T3 (en) 2010-08-16 2016-10-24 Santhera Pharmaceuticals (Schweiz) Ag Benzoquinonderivater for the treatment of mitochondrial diseases of the eye
CN103086861B (zh) * 2012-11-12 2015-09-16 刘炜 羟癸基苯醌衍生物及其用途
WO2021127003A1 (en) * 2019-12-16 2021-06-24 Children's Medical Center Corporation Treating heart disease in muscular dystrophy patients
WO2022258629A1 (en) 2021-06-07 2022-12-15 Katholieke Universiteit Leuven Idebenone in the treatment of drug resistant epilepsy
CN113827585B (zh) * 2021-10-27 2023-04-11 山东大学齐鲁医院 艾地苯在治疗肢带型肌营养不良2g型中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8562998A (en) 1997-08-12 1999-03-01 Takeda Chemical Industries Ltd. Idebenone-containing preparation for percutaneous administration
JPH11116470A (ja) 1997-08-12 1999-04-27 Takeda Chem Ind Ltd イデベノン含有経皮投与製剤
US20030013772A1 (en) * 2000-02-23 2003-01-16 Murphy Michael A. Composition, synthesis and therapeutic applications of polyamines
CA2272971C (en) * 1998-10-29 2008-01-15 Institut National De La Sante Et De La Recherche Medicale (Inserm) Quinone derivatives for treating or preventing diseases associated with iron overload
US20040081961A1 (en) * 2001-05-04 2004-04-29 Delegeane Angelo M Proteases
EP1618881A1 (en) * 2004-07-20 2006-01-25 Santhera Pharmaceuticals (Schweiz) GmbH Use of non-glucocorticoid steroids for the treatment of muscular dystrophy

Also Published As

Publication number Publication date
AU2006226623A1 (en) 2006-09-28
EP1861080A1 (en) 2007-12-05
DK1861080T3 (da) 2010-09-06
JP2008533182A (ja) 2008-08-21
ATE468849T1 (de) 2010-06-15
EP1861080B1 (en) 2010-05-26
JP4896123B2 (ja) 2012-03-14
PL1861080T3 (pl) 2010-10-29
NZ561235A (en) 2010-12-24
AU2006226623B2 (en) 2010-04-22
ES2345353T3 (es) 2010-09-21
CA2602290A1 (en) 2006-09-28
SI1861080T1 (sl) 2010-08-31
WO2006100017A1 (en) 2006-09-28
US7977388B2 (en) 2011-07-12
US20090012050A1 (en) 2009-01-08
MX2007011571A (es) 2007-12-06
CY1110182T1 (el) 2015-01-14
ZA200707833B (en) 2008-06-25
PT1861080E (pt) 2010-06-17
CA2602290C (en) 2012-01-17

Similar Documents

Publication Publication Date Title
CY1110182T1 (el) Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
EP1991218A4 (en) USE OF CYCLOLIGNANS IN THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES
WO2003087303A3 (en) Tissue composites and uses thereof
PL2436338T3 (pl) Urządzenie do leczenia zwieraczy tkanki ciała i tym podobnych
WO2004103301A3 (en) Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents
IL194153A0 (en) Compounds for the treatment of spinal muscular atrophy and other uses
WO2007146426A3 (en) Nanoshells for drug delivery
EP1784163A4 (en) NANOEMULSION, USE THEREOF AND PROCESS FOR PREPARING THE SAME
IL196965A (en) Analogues of (r, r) or (s, r) phenoterol, their pharmaceutical composition containing them and their use for the treatment of heart failure
EP1970002A4 (en) CUFF OF A BLOOD PRESSURE METER AND BLOOD PRESSURE METER THEREFOR
IL219671A0 (en) 1,2- benzoxazoles and use thereof in the preparation of a medicament
SI1978947T1 (sl) Nitrooksiderivati za uporabo pri zdravljenju mišičnih distrofij
IL198200A0 (en) Use of estradiol valerate or 17??-estradiol in combination with dienogest for oral therapy for maintaining and/or increasing the female libido
NZ577392A (en) Use of 3-alpha-androstanediol, optionally in combination with a 5-ht1a agonist, in the treatment of sexual dysfunction
GB0427568D0 (en) Particle-size reduction apparatus, and the use thereof
MX2009011294A (es) Combinacion de farmacos y su uso en el tratamiento de la perdida muscular.
EP2005964A4 (en) MEDICAMENT FOR TREATING HYPERPHOSPHATEEMIA AND PREPARATION METHOD THEREOF
MX2009008873A (es) Composicion util para el tratamiento de diabetes tipo 2.
ZA201005398B (en) 15,16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative,use thereof,and medicament containing said derivative
AU302434S (en) Vibroheat capsule I
PL1732487T3 (pl) Plaster medyczny do stosowania na skórę
ZA200900938B (en) Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure
GB0310147D0 (en) A composition for use in the treatment of a skin condition in a subject
IL206381A0 (en) 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
HK1153406A (en) Piperlongumine and piperlongumine analogs for use in the treatment of cancer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition